Changes in eotaxin-2 and periostin levels in patients with bronchial asthma according to their smoking status: a cross-sectional study

Background Smoking influences the nature of airway inflammation in patients with bronchial asthma though synthesis of certain cytokines. Patterns of bronchial asthma are differentiated clinically, functionally, and regarding inflammatory biomarkers. Aim The research aimed to study the clinical, func...

Full description

Bibliographic Details
Main Authors: Mohammed F Abdelghany, Atef F El-Karn, Mahmoud F Sherif, Mohamed I Seddik, Safaa A Eid, Sahar F Youssif
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=3;spage=305;epage=312;aulast=Abdelghany
_version_ 1797738800422584320
author Mohammed F Abdelghany
Atef F El-Karn
Mahmoud F Sherif
Mohamed I Seddik
Safaa A Eid
Sahar F Youssif
author_facet Mohammed F Abdelghany
Atef F El-Karn
Mahmoud F Sherif
Mohamed I Seddik
Safaa A Eid
Sahar F Youssif
author_sort Mohammed F Abdelghany
collection DOAJ
description Background Smoking influences the nature of airway inflammation in patients with bronchial asthma though synthesis of certain cytokines. Patterns of bronchial asthma are differentiated clinically, functionally, and regarding inflammatory biomarkers. Aim The research aimed to study the clinical, functional, sputum cytological differences, and serum eotaxin-2 and periostin levels in asthmatic patients regarding smoking status. Patients and methods The research was a cross-sectional study. The collection of cases began in August 2018 and ended in January 2020 at the Chest Department, Assiut University Hospital. We studied 117 asthmatic patients who were classified regarding their smoking status (45 nonsmokers, 42 smokers, and 30 former smokers) for serum eotaxin-2 and periostin by enzyme-linked immunosorbent assay. The effects of smoking were analyzed on inflammatory cells including eosinophilic and neutrophilic percentages in sputum and serum eotaxin-2 and periostin levels. Results Smokers with asthma had worse clinical and functional outcomes. Asthmatic smokers had mainly neutrophilic phenotype. Serum eotaxin-2 level was higher in smokers compared with nonsmokers and former smokers. However, serum periostin level was higher in nonsmokers compared with smokers and former smokers. Serum eotaxin-2 had a positive correlation with smoking index and eosinophilic and neutrophilic count in sputum, whereas serum periostin was correlated negatively with smoking index and positively with eosinophilic count. Conclusion Asthmatic smokers had worse clinical and functional outcomes with increased neutrophils in the sputum. The inflammatory biomarkers seen in smokers with asthma showed low serum periostin and increased serum eotaxin-2 levels.
first_indexed 2024-03-12T13:49:02Z
format Article
id doaj.art-69e22002966941d49ab20bd720c60bac
institution Directory Open Access Journal
issn 0422-7638
2090-9950
language English
last_indexed 2024-03-12T13:49:02Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Egyptian Journal of Chest Disease and Tuberculosis
spelling doaj.art-69e22002966941d49ab20bd720c60bac2023-08-23T07:29:34ZengWolters Kluwer Medknow PublicationsEgyptian Journal of Chest Disease and Tuberculosis0422-76382090-99502023-01-0172330531210.4103/ecdt.ecdt_91_22Changes in eotaxin-2 and periostin levels in patients with bronchial asthma according to their smoking status: a cross-sectional studyMohammed F AbdelghanyAtef F El-KarnMahmoud F SherifMohamed I SeddikSafaa A EidSahar F YoussifBackground Smoking influences the nature of airway inflammation in patients with bronchial asthma though synthesis of certain cytokines. Patterns of bronchial asthma are differentiated clinically, functionally, and regarding inflammatory biomarkers. Aim The research aimed to study the clinical, functional, sputum cytological differences, and serum eotaxin-2 and periostin levels in asthmatic patients regarding smoking status. Patients and methods The research was a cross-sectional study. The collection of cases began in August 2018 and ended in January 2020 at the Chest Department, Assiut University Hospital. We studied 117 asthmatic patients who were classified regarding their smoking status (45 nonsmokers, 42 smokers, and 30 former smokers) for serum eotaxin-2 and periostin by enzyme-linked immunosorbent assay. The effects of smoking were analyzed on inflammatory cells including eosinophilic and neutrophilic percentages in sputum and serum eotaxin-2 and periostin levels. Results Smokers with asthma had worse clinical and functional outcomes. Asthmatic smokers had mainly neutrophilic phenotype. Serum eotaxin-2 level was higher in smokers compared with nonsmokers and former smokers. However, serum periostin level was higher in nonsmokers compared with smokers and former smokers. Serum eotaxin-2 had a positive correlation with smoking index and eosinophilic and neutrophilic count in sputum, whereas serum periostin was correlated negatively with smoking index and positively with eosinophilic count. Conclusion Asthmatic smokers had worse clinical and functional outcomes with increased neutrophils in the sputum. The inflammatory biomarkers seen in smokers with asthma showed low serum periostin and increased serum eotaxin-2 levels.http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=3;spage=305;epage=312;aulast=Abdelghanyasthmabiomarkerseosinophileotaxin-2neutrophilperiostinsmoker
spellingShingle Mohammed F Abdelghany
Atef F El-Karn
Mahmoud F Sherif
Mohamed I Seddik
Safaa A Eid
Sahar F Youssif
Changes in eotaxin-2 and periostin levels in patients with bronchial asthma according to their smoking status: a cross-sectional study
Egyptian Journal of Chest Disease and Tuberculosis
asthma
biomarkers
eosinophil
eotaxin-2
neutrophil
periostin
smoker
title Changes in eotaxin-2 and periostin levels in patients with bronchial asthma according to their smoking status: a cross-sectional study
title_full Changes in eotaxin-2 and periostin levels in patients with bronchial asthma according to their smoking status: a cross-sectional study
title_fullStr Changes in eotaxin-2 and periostin levels in patients with bronchial asthma according to their smoking status: a cross-sectional study
title_full_unstemmed Changes in eotaxin-2 and periostin levels in patients with bronchial asthma according to their smoking status: a cross-sectional study
title_short Changes in eotaxin-2 and periostin levels in patients with bronchial asthma according to their smoking status: a cross-sectional study
title_sort changes in eotaxin 2 and periostin levels in patients with bronchial asthma according to their smoking status a cross sectional study
topic asthma
biomarkers
eosinophil
eotaxin-2
neutrophil
periostin
smoker
url http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=3;spage=305;epage=312;aulast=Abdelghany
work_keys_str_mv AT mohammedfabdelghany changesineotaxin2andperiostinlevelsinpatientswithbronchialasthmaaccordingtotheirsmokingstatusacrosssectionalstudy
AT ateffelkarn changesineotaxin2andperiostinlevelsinpatientswithbronchialasthmaaccordingtotheirsmokingstatusacrosssectionalstudy
AT mahmoudfsherif changesineotaxin2andperiostinlevelsinpatientswithbronchialasthmaaccordingtotheirsmokingstatusacrosssectionalstudy
AT mohamediseddik changesineotaxin2andperiostinlevelsinpatientswithbronchialasthmaaccordingtotheirsmokingstatusacrosssectionalstudy
AT safaaaeid changesineotaxin2andperiostinlevelsinpatientswithbronchialasthmaaccordingtotheirsmokingstatusacrosssectionalstudy
AT saharfyoussif changesineotaxin2andperiostinlevelsinpatientswithbronchialasthmaaccordingtotheirsmokingstatusacrosssectionalstudy